• In late April 2026, CRH plc reported first-quarter results showing revenue rising to US$7,370 million, a net loss of US$176 million including US$48 million of asset impairments, and simultaneously reaffirmed full-year 2026 guidance for net income of US$3.90–US$4.10 billion and diluted EPS of US$5.60–US$6.05.
• Alongside the earnings release, CRH highlighted active portfolio reshaping with around US$1.90 billion of non-core divestitures and roughly US$900 million of acquisitions, sharpening its focus on higher-return infrastructure and water-related businesses.
• We’ll now examine how CRH’s reaffirmed 2026 earnings guidance, despite a first-quarter loss, may influence its longer-term investment narrative.

The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

CRH Investment Narrative Recap

To own CRH, you need to believe in its ability to convert a large, infrastructure and water focused portfolio into consistent earnings, even with seasonally weak quarters. The reaffirmed 2026 guidance after a first quarter loss does not materially change the near term catalyst around U.S. infrastructure spending, but it does keep execution risk around acquisitions and integration firmly in focus.

Among recent announcements, CRH’s agreement to divest around US$1.90 billion of non core assets and commit roughly US$900 million to acquisitions such as Axius Water is most relevant here, because it tightens the link between portfolio reshaping and the company’s ability to meet its reaffirmed earnings targets.

Yet investors should be aware that heavy dependence on publicly funded U.S. infrastructure means any shift in government priorities could...

CRH’s narrative projects $44.1 billion in revenue and $4.9 billion in earnings by 2029.

Uncover how CRH's forecasts yield a $142.95 fair value, a 29% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community fair value estimates for CRH range from US$106.42 to US$142.95, underlining how far apart individual views can be. When you set that against CRH’s reliance on ongoing U.S. infrastructure funding, it becomes even more important to compare several perspectives on what could drive or limit future performance.

Explore 3 other fair value estimates on CRH - why the stock might be worth as much as 29% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your CRH research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free CRH research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CRH's overall financial health at a glance.

Searching For A Fresh Perspective?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Find 48 companies with promising cash flow potential yet trading below their fair value.
• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 32 companies in the world exploring or producing it. Find the list for free.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.